Voriconazole (Vfend) Drug Use Investigation (Regulatory Post Marketing Commitment Plan)

Pfizer

Status: Completed

Conditions: Systemic Mycosis

Treatments: Drug: Voriconazole

Study type: Observational

Funder types: Industry

Identifiers

NCT01151085

A1501076

Details and patient eligibility

About

To collect the efficacy and safety informations of voriconazole related to their appropriate use in daily practice.

Full description

All the subjects whom an investigator prescribes the first voriconazole (VFEND) should be registered consecutively until the number of subjects reaches target number in order to extract subjects enrolled into the investigation at random.

Enrollment: 1,002 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Male or Female subjects intend to treat their deep mycosis who are prescribed voriconazole (VFEND) by their Physicians.

Exclusion criteria

• Subject who heve been prescribed voriconazole (VFEND) before.

Trial design

1,002 participants in 1 patient group

Voriconazole

Description:

Subjects who are treated with voriconazole

Treatment:

Drug: Voriconazole